The impact of stronger drug dosing patents on Canadian drug access

In this article — "The impact of stronger drug dosing patents on Canadian drug access" — we discuss the importance of an effective balance between patent enforceability and timely access to affordable generic drugs if prescription drug costs are to be better managed. Recent jurisprudence suggests this balance may be shifting away from affordable alternatives.  Further developments on this front are expected in the coming year.This article is authored by J. Bradley White, partner and Co-Chair, Intellectual Property practice along with Nathaniel Lipkus, partner and Leah McGurn, an associate both also with Osler’s Intellectual Property practice.Osler Legal Outlook is brought to you by Osler, Hoskin & Harcourt LLP. Osler is a leading, national law firm with a singular focus — your business. We advise clients on an array of domestic and cross-border legal issues, drawing on the expertise of over 600 lawyers to provide the answers you need, when you need them.Osler Legal Outlook provides general information only and does not constitute legal or other professional advice. Specific advice should be sought in connection with your circumstances.For more information about Osler and for the full Osler Legal Outlook, please visit our website at osler.com.